Your browser doesn't support javascript.
loading
Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina.
Shahandeh, Ali; Bui, Bang V; Finkelstein, David I; Nguyen, Christine T O.
Affiliation
  • Shahandeh A; Department of Optometry and Vision Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Bui BV; Department of Optometry and Vision Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Finkelstein DI; Florey Department of Neuroscience and Mental Health, Parkville, VIC, Australia.
  • Nguyen CTO; Department of Optometry and Vision Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
J Neurosci Res ; 98(10): 1889-1904, 2020 10.
Article in En | MEDLINE | ID: mdl-32643793
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Retinal Diseases / Brain Diseases / Iron Chelating Agents / Iron Limits: Animals / Humans Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Retinal Diseases / Brain Diseases / Iron Chelating Agents / Iron Limits: Animals / Humans Language: En Year: 2020 Type: Article